Cargando…

The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers

Cardiovascular diseases (CVDs) are the leading cause of death and illness in Europe and worldwide, responsible for a staggering 47% of deaths in Europe. Over the past few years, there has been increasing evidence pointing to bioactive sphingolipids as drivers of CVDs. Among them, most studies place...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Pietro, Paola, Izzo, Carmine, Abate, Angela Carmelita, Iesu, Paola, Rusciano, Maria Rosaria, Venturini, Eleonora, Visco, Valeria, Sommella, Eduardo, Ciccarelli, Michele, Carrizzo, Albino, Vecchione, Carmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855992/ https://www.ncbi.nlm.nih.gov/pubmed/36671552 http://dx.doi.org/10.3390/biom13010168

Ejemplares similares

The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2021)

A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases
por: Carrizzo, Albino, et al.
Publicado: (2020)

A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm(®)) and Anthocyanins Exerts Beneficial Cardiovascular Effects
por: Di Pietro, Paola, et al.
Publicado: (2022)

Healthberry 865(®) and Its Related, Specific, Single Anthocyanins Exert a Direct Vascular Action, Modulating Both Endothelial Function and Oxidative Stress
por: Carrizzo, Albino, et al.
Publicado: (2021)

Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems
por: Visco, Valeria, et al.
Publicado: (2022)

Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)
por: Ciccarelli, Michele, et al.
Publicado: (2022)

Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve
por: Visco, Valeria, et al.
Publicado: (2023)

Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work
por: Visco, Valeria, et al.
Publicado: (2023)

Editorial: The role of metabolic syndrome and disorders in cardiovascular disease
por: Di Pietro, Paola, et al.
Publicado: (2023)

Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art
por: Calabrese, Mariaconsiglia, et al.
Publicado: (2021)

A Novel Vasoactive Peptide “PG1” from Buffalo Ice-Cream Protects from Angiotensin-Evoked High Blood Pressure
por: Carrizzo, Albino, et al.
Publicado: (2021)

Vitamin D: Not Just Bone Metabolism but a Key Player in Cardiovascular Diseases
por: Izzo, Marcello, et al.
Publicado: (2021)

Targeting the ASMase/S1P pathway protects from sortilin-evoked vascular damage in hypertension
por: Di Pietro, Paola, et al.
Publicado: (2022)

Timing of national lockdown and mortality in COVID-19: The Italian experience
por: Silverio, Angelo, et al.
Publicado: (2020)

New Nutraceutical Combination Reduces Blood Pressure and Improves Exercise Capacity in Hypertensive Patients Via a Nitric Oxide–Dependent Mechanism
por: Carrizzo, Albino, et al.
Publicado: (2020)

Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients
por: Campanile, Alfonso, et al.
Publicado: (2023)

The “Dark Side” of Pneumoperitoneum and Laparoscopy
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2021)

Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity
por: Puca, Annibale Alessandro, et al.
Publicado: (2012)

Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF
por: Visco, Valeria, et al.
Publicado: (2022)

Cardiac Rehabilitation Increases SIRT1 Activity and β-Hydroxybutyrate Levels and Decreases Oxidative Stress in Patients with HF with Preserved Ejection Fraction
por: Corbi, Graziamaria, et al.
Publicado: (2019)

A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS
por: Visco, Valeria, et al.
Publicado: (2022)

SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency
por: Carrizzo, Albino, et al.
Publicado: (2022)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
por: Conti, Valeria, et al.
Publicado: (2020)

β-Lactoglobulin Heptapeptide Reduces Oxidative Stress in Intestinal Epithelial Cells and Angiotensin II-Induced Vasoconstriction on Mouse Mesenteric Arteries by Induction of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Translocation
por: Pepe, Giacomo, et al.
Publicado: (2019)

The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation
por: Carrizzo, Albino, et al.
Publicado: (2018)

The Role of BPIFB4 in Immune System and Cardiovascular Disease: The Lesson from Centenarians
por: Montella, Francesco, et al.
Publicado: (2021)

Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases
por: Forte, Maurizio, et al.
Publicado: (2016)

BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19
por: Ciaglia, Elena, et al.
Publicado: (2021)

Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38(+) macrophages and NAD(+) decline
por: Ciaglia, Elena, et al.
Publicado: (2022)

Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
por: Carrizzo, Albino, et al.
Publicado: (2014)

PTX3: an inflammatory protein modulating ultrastructure and bioenergetics of human endothelial cells
por: Carrizzo, Albino, et al.
Publicado: (2019)

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
por: Silverio, Angelo, et al.
Publicado: (2022)

Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease
por: Strianese, Oriana, et al.
Publicado: (2020)

Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn’s Disease
por: Russo, Ilaria, et al.
Publicado: (2018)

siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn’s Disease
por: Russo, Ilaria, et al.
Publicado: (2018)

The Impact of Aging on Cardio and Cerebrovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2018)

The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions
por: Sorriento, Daniela, et al.
Publicado: (2021)

Vasorelaxing Action of the Kynurenine Metabolite, Xanthurenic Acid: The Missing Link in Endotoxin-Induced Hypotension?
por: Fazio, Francesco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2snlej5s1u72a8245eh0q2omtt